1,287,265 Shares in Agilent Technologies, Inc. $A Acquired by William Blair Investment Management LLC

William Blair Investment Management LLC bought a new stake in Agilent Technologies, Inc. (NYSE:A) during the 2nd quarter, HoldingsChannel reports. The fund bought 1,287,265 shares of the medical research company’s stock, valued at approximately $170,987,000.

Several other hedge funds have also recently added to or reduced their stakes in the business. Korea Investment CORP acquired a new position in Agilent Technologies during the 2nd quarter worth $15,434,000. EP Wealth Advisors LLC bought a new position in shares of Agilent Technologies in the second quarter worth $1,552,000. Ieq Capital LLC acquired a new position in shares of Agilent Technologies during the second quarter valued at $23,489,000. Callan Family Office LLC acquired a new position in shares of Agilent Technologies during the second quarter valued at $2,222,000. Finally, Keebeck Wealth Management bought a new stake in shares of Agilent Technologies during the second quarter valued at about $226,000.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on A shares. Bank of America raised shares of Agilent Technologies from a “neutral” rating to a “buy” rating and reduced their price objective for the stock from $150.00 to $145.00 in a report on Thursday, May 28th. Jefferies Financial Group began coverage on shares of Agilent Technologies in a report on Thursday, July 9th. They issued a “hold” rating and a $135.00 price objective for the company. Piper Sandler assumed coverage on shares of Agilent Technologies in a research note on Thursday, June 11th. They set a “neutral” rating and a $150.00 price objective on the stock. Royal Bank Of Canada assumed coverage on Agilent Technologies in a report on Wednesday, May 27th. They set an “outperform” rating and a $153.00 target price on the stock. Finally, TD Cowen increased their price target on Agilent Technologies from $147.00 to $155.00 and gave the company a “buy” rating in a research note on Thursday, May 28th. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $160.24.

Agilent Technologies Price Performance

Shares of NYSE A opened at $159.25 on Friday. Agilent Technologies, Inc. has a twelve month low of $108.35 and a twelve month high of $160.51. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43. The company has a market capitalization of $44.98 billion, a price-to-earnings ratio of 31.98, a PEG ratio of 2.77 and a beta of 1.25. The firm has a 50-day moving average of $137.57 and a two-hundred day moving average of $126.23.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The company had revenue of $1.83 billion for the quarter, compared to analysts’ expectations of $1.80 billion. During the same quarter in the previous year, the company posted $1.31 EPS. The business’s revenue was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, analysts expect that Agilent Technologies, Inc. will post 6.03 earnings per share for the current fiscal year.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.